PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes

Journal of Virology
Tatsuyoshi KawamuraShannon E Bruce

Abstract

Topical microbicides that effectively block interactions between CCR5(+) immature Langerhans cells (LC) residing within genital epithelia and R5 human immunodeficiency virus (HIV) may decrease sexual transmission of HIV. Here, we investigated the ability of synthetic RANTES analogues (AOP-, NNY-, and PSC-RANTES) to block R5 HIV infection of human immature LC by using a skin explant model. In initial experiments using activated peripheral blood mononuclear cells, each analogue compound demonstrated marked antiviral activity against two R5 HIV isolates. Next, we found that 20-min preincubation of skin explants with each RANTES analogue blocked R5 HIV infection of LC in a dose-dependent manner (1 to 100 nM) and that PSC-RANTES was the most potent of these compounds. Similarly, preincubation of LC with each analogue was able to block LC-mediated infection of cocultured CD4(+) T cells. Competition experiments between primary R5 and X4 HIV isolates showed blocking of R5 HIV by PSC-RANTES and no evidence of increased propagation of X4 HIV, data that are consistent with the specificity of PSC-RANTES for CCR5 and the CCR5(+) CXCR4(-) phenotype of immature LC. Finally, when CCR5 genetic polymorphism data were integrated with results from...Continue Reading

References

Apr 10, 1997·The New England Journal of Medicine·R A RoyceM S Cohen
Apr 26, 1997·Lancet·T R O'BrienG C White
Jun 13, 1998·The Journal of Experimental Medicine·J C ReeceP U Cameron
Jul 2, 1998·The New England Journal of Medicine·J O Kahn, B D Walker
Aug 27, 1999·JAMA : the Journal of the American Medical Association·H ValdezP A Zimmerman
Sep 30, 1999·The New England Journal of Medicine·A S Fauci
Feb 13, 2001·Clinical Immunology : the Official Journal of the Clinical Immunology Society·J R SalkowitzM M Lederman
Aug 1, 2002·Proceedings of the National Academy of Sciences of the United States of America·Michael J BamshadSunil K Ahuja
Jan 15, 2003·Annual Review of Medicine·Mary Carrington, Stephen J O'Brien
Jan 25, 2003·Antimicrobial Agents and Chemotherapy·Cristina PastoreDonald E Mosier
Feb 21, 2003·Microbes and Infection·Christopher J Miller, Robin J Shattock
May 15, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Polly F HarrisonJana Bowcut
Jun 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Tatsuyoshi KawamuraAndrew Blauvelt
Jul 2, 2003·Nature Medicine·Melissa Pope, Ashley T Haase
Sep 17, 2003·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Nikolaus RomaniPatrizia Stoitzner
Sep 23, 2003·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Janelle R SalkowitzMichael M Lederman

❮ Previous
Next ❯

Citations

Nov 13, 2008·Pharmaceutical Research·Anthony S HamLisa Cencia Rohan
Nov 14, 2008·Proceedings of the National Academy of Sciences of the United States of America·Hubert GaertnerOliver Hartley
Jan 13, 2012·Protein Engineering, Design & Selection : PEDS·Yingping WuWenyan Wu
Sep 9, 2008·The Journal of Clinical Investigation·Marein A W P de JongTeunis B H Geijtenbeek
Jul 17, 2013·Experimental Biology and Medicine·Horst A von Recum, Jonathan K Pokorski
Jun 2, 2011·Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology·Tatsuyoshi Kawamura
Oct 7, 2011·Uirusu·Tatsuyoshi Kawamura
Nov 17, 2004·Proceedings of the National Academy of Sciences of the United States of America·Oliver HartleyRobin Offord
Aug 10, 2011·Biochemical Pharmacology·Andy ChevignéSabrina Deroo
May 8, 2013·The Journal of Investigative Dermatology·Takamitsu MatsuzawaShinji Shimada
Feb 18, 2010·Reproductive Biomedicine Online·Poornima Chandran, Syed N Kabir
Jan 27, 2007·The Journal of Investigative Dermatology·Makoto SugayaAndrew Blauvelt
Dec 7, 2007·Trends in Molecular Medicine·Lot de WitteTeunis B H Geijtenbeek
Aug 3, 2013·Reviews in Medical Virology·Andrew N HarmanPaul U Cameron
Mar 18, 2011·Reviews in Medical Virology·Kevin K AriënGuido Vanham
Nov 14, 2006·Biologicals : Journal of the International Association of Biological Standardization·Ian McGowan
Oct 18, 2005·Journal of Dermatological Science·Tatsuyoshi KawamuraShinji Shimada
Nov 11, 2008·The Lancet Infectious Diseases·Blayne Cutler, Jessica Justman
Aug 16, 2005·Expert Review of Proteomics·Oliver K BernhardAnthony L Cunningham
Apr 5, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Valerie MarsdenAnthony L Cunningham
May 5, 2006·Advances in Dental Research·M C HerzbergS M Wahl
Aug 23, 2006·Journal of Leukocyte Biology·Heather DonaghyAnthony L Cunningham
Jan 12, 2011·Expert Opinion on Therapeutic Patents·Inder Pal Singh, Siddheshwar K Chauthe
Jun 11, 2011·The Journal of Biological Chemistry·Bo ZhaoPatricia J Liwang
Jul 30, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Najla NasrAnthony L Cunningham
Feb 23, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tatsuyoshi KawamuraShinji Shimada
Jun 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Claudia N RennRobert L Modlin
Apr 8, 2020·ACS Pharmacology & Translational Science·Olav LarsenMette M Rosenkilde
Jul 6, 2014·Retrovirology·Ramin Sarrami-ForooshaniTeunis B H Geijtenbeek

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.